V031-2309 Screening compound: 2-(2,2-diphenylacetamido)-3-methyl-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]butanamide

V031-2309 Screening compound: 2-(2,2-diphenylacetamido)-3-methyl-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]butanamide
V031-2309 Screening compound: 2-(2,2-diphenylacetamido)-3-methyl-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V031-2309
2-(2,2-diphenylacetamido)-3-methyl-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V031-2309

Molecular Formula

C28H28N4O2S (C28 H28 N4 O2 S)

Compound Name

2-(2,2-diphenylacetamido)-3-methyl-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]butanamide

IUPAC name

2-(22-diphenylacetamido)-3-methyl-N-[5-(4-methylphenyl)-134-thiadiazol-2-yl]butanamide

SMILES

CC(C)C(C(Nc1nnc(-c2ccc(C)cc2)s1)=O)NC(C(c1ccccc1)c1ccccc1)=O

InChI

InChI=1S/C28H28N4O2S/c1-18(2)24(26(34)30-28-32-31-27(35-28)22-16-14-19(3)15-17-22)29-25(33)23(20-10-6-4-7-11-20)21-12-8-5-9-13-21/h4-18,23-24H,1-3H3,(H,29,33)(H,30,32,34)/t24-/m0/s1

InChI Key

WSQGOOIXJPQIAS-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD20010683

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

484.62

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.925

Distribution Coefficient, logD

5.924

Water Solubility, LogSw

-5.64

Polar Surface Area

70.368

Acid Dissociation Constant (pKa)

10.27

Base Dissociation Constant (pKb)

-1.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

21.40

V031-2309 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V031-2309 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V031-2309?
Check Price and Availability of V031-2309, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V031-2309 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V031-2309
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V031-2309
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V031-2309 available by request